xenon xe-127 Report issue

Small molecule Imaging Approved FDA
ChEMBL Drug Central Drugs@FDA PubChem

Active Ingredient History

NOW
  • Now
XENON XE-127, a radioactive gas, was developed at Brookhaven National Laboratory in 1973 for lung ventilation imaging. It appears to be preferable to xenon-133 because of the higher counting rates, lower patient radiation dose, and longer shelf life. However, its production ceased in 1993 due to various reasons.   NCATS

Chemistry

More Chemistry

Pharmacology

  • Mechanisms of Action:
  • Multi-specific: Missing data
  • Imaging: 127-xenon
  • Black Box: No
  • Availability: Discontinued
  • Delivery Methods: Topical
  • Pro Drug: No

Alternative names

127xe | xe 127 | xenon-127 | xenon (127xe) | xenon (127xe) gas | xenon xe 127 | xenon xe-127

Organizations (2)

Research & Development (0)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (2)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (2)

Approved Indications (2)


 

Cerebrovascular Disorders (approved 1982)

Lung Diseases (approved 1982)

Experimental Indications - Clinical Trial Phases 1-4 (0)

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue